SAM
Sectoral Asset Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $713K | Hold |
15,108
| – | – | 0.47% | 55 |
|
|
2025
Q1 | $590K | Sell |
15,108
-8,579
| -36% | -$335K | 0.46% | 50 |
|
|
2024
Q4 | $1.28M | Sell |
23,687
-3,571
| -13% | -$193K | 0.86% | 31 |
|
|
2024
Q3 | $1.37M | Buy |
27,258
+5,830
| +27% | +$294K | 0.81% | 40 |
|
|
2024
Q2 | $942K | Sell |
21,428
-24,867
| -54% | -$1.09M | 0.38% | 55 |
|
|
2024
Q1 | $2.33M | Buy |
46,295
+16,290
| +54% | +$818K | 0.91% | 34 |
|
|
2023
Q4 | $1.81M | Sell |
30,005
-67,960
| -69% | -$4.1M | 0.78% | 52 |
|
|
2023
Q3 | $5.58M | Sell |
97,965
-86,625
| -47% | -$4.94M | 1.09% | 34 |
|
|
2023
Q2 | $9.41M | Buy |
+184,590
| New | +$9.41M | 1.57% | 19 |
|